Locations:
SearchLearn about featured cancer clinical trials currently enrolling, or search our cancer clinical trials database for all open and accruing studies.
Renal
A Phase II study of the efficacy and safety of Axitinib given on an individualized schedule for metastatic renal cell cancer after treatment with PD-1 or PD-l1 inhibitor
CASE 7815
View full trial information.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Leukemia, Chronic Myelomonocytic (CMML)
A Phase 2 Study of Tipifarnib in Subjects with Chronic Myelomonocytic Leukemia
KURA 1916
View full trial information.
Paroxysmal Nocturnal Hemoglobinuria (PNH)
A Phase 3, Randomized, Open-Label, Active-Controlled Study of ALXN1210 Versus Eculizumab in Complement Inhibitor-Naïve Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
ALEX 1Z16
View full trial information.
Lymphoma
p53/p16-Independent Epigenetic Therapy with Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies
CASE 1416
View full trial information.
Search our Cancer Clinical Trials Database for a full listing of all open and accruing studies.
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Gene editing technology offers promise for treating multiple myeloma and other hematologic malignancies, as well as solid tumors
Study of 401,576 patients reveals differences in cancer burdens as well as overall survival
Enfortumab plus pembrolizumab reduced risk of death by 53% compared with platinum-based chemotherapy